Risk factors associated with fatigue in chronic hepatitis B patients

References

• Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1–98.
   PubMed Web of Science ®Google Scholar
• Lu JB, Cai SH, Pan YH, Yun JP. Altered epidermal fatty acid-binding protein expression in hepatocellular carcinoma predicts unfavorable outcomes. Cancer Manag Res. 2018;10:6275–6284. doi:10.2147/CMAR.S18155530538573
   PubMed Web of Science ®Google Scholar
• Xiao YB, Cai SH, Liu LL, Yang X, Yun JP. Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma. Cancer Manag Res. 2018;10:1781–1789. doi:10.2147/CMAR.S16697129983595
   PubMed Web of Science ®Google Scholar
• Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661–662. doi:10.1002/hep.2319019714720
   PubMed Web of Science ®Google Scholar
• Cai S, Cao J, Yu T, Xia M, Peng J. Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine. Medicine (Baltimore). 2017;96:e7021. doi:10.1097/MD.000000000000702128562554
   PubMed Web of Science ®Google Scholar
• European Association for the Study of Liver 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370–398. doi:10.1016/j.jhep.2017.03.02128427875
   PubMed Web of Science ®Google Scholar
• Cai S, Li Z, Yu T, Xia M, Peng J. Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs. Infect Drug Resist. 2018;11:469–477. doi:10.2147/IDR.S16303829662321
   PubMed Web of Science ®Google Scholar
• Cai S, Ou Z, Liu D, et al. Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome. United European Gastroenterol J. 2018;6:558–566. doi:10.1177/2050640617751252
   PubMed Web of Science ®Google Scholar
• Cai S, Yu T, Jiang Y, Zhang Y, Lv F, Peng J. Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result. Clin Exp Med. 2016;16:429–436. doi:10.1007/s10238-015-0373-226164128
   PubMed Web of Science ®Google Scholar
• Xue X, Cai S. Comment on “Assessment of liver stiffness in pediatric fontan patients using transient elastography”. Can J Gastroenterol Hepatol. 2016;2016:9343960. doi:10.1155/2016/934396028025635
   PubMed Web of Science ®Google Scholar
• Cai SH, Lv FF, Zhang YH, Jiang YG, Peng J. Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB. BMC Infect Dis. 2014;14:85. doi:10.1186/1471-2334-14-8524528480
   PubMed Web of Science ®Google Scholar
• Wu X, Cai S, Li Z, et al. Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysis. Virol J. 2016;13:64. doi:10.1186/s12985-016-0512-827062520
   PubMed Web of Science ®Google Scholar
• Ou H, Cai S, Liu Y, Xia M, Peng J. A noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis B. Therap Adv Gastroenterol. 2017;10:207–217. doi:10.1177/1756283X16681707
   PubMed Web of Science ®Google Scholar
• Zeng J, Cai S, Liu J, Xue X, Wu X, Zheng C. Dynamic changes in liver stiffness measured by transient elastography predict clinical outcomes among patients with chronic hepatitis B. J Ultrasound Med. 2017;36:261–268. doi:10.7863/ultra.15.1205427914175
   PubMed Web of Science ®Google Scholar
• Cai SH, Lu SX, Liu LL, Zhang CZ, Yun JP. Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinoma. Therap Adv Gastroenterol. 2017;10:761–771. doi:10.1177/1756283X17725998
   PubMed Web of Science ®Google Scholar
• Xue X, Cai S, Ou H, Zheng C, Wu X. Health-related quality of life in patients with chronic hepatitis B during antiviral treatment and off-treatment. Patient Prefer Adherence. 2017;11:85–93. doi:10.2147/PPA.S12713928138226
   PubMed Web of Science ®Google Scholar
• Lai W, Cai S. Comment on “Prevalence of anxiety and depression in patients with inflammatory bowel disease”. Can J Gastroenterol Hepatol. 2018;2018:6747630. doi:10.1155/2018/674763030643760
   PubMed Web of Science ®Google Scholar
• Evon DM, Wahed AS, Johnson G, et al. Fatigue in patients with chronic hepatitis B living in North America: results from the Hepatitis B Research Network (HBRN). Dig Dis Sci. 2016;61:1186–1196. doi:10.1007/s10620-015-4006-026831489
   PubMed Web of Science ®Google Scholar
• Jang Y, Kim JH, Lee K. Validation of the revised piper fatigue scale in Koreans with chronic hepatitis B. PLoS One. 2017;12:e177690. doi:10.1371/journal.pone.0177690
   PubMed Web of Science ®Google Scholar
• European Association for the Study of Liver clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012;57:399–420. doi:10.1016/j.jhep.2012.04.00422633836
   PubMed Web of Science ®Google Scholar
• Modabbernia A, Ashrafi M, Malekzadeh R, Poustchi H. A review of psychosocial issues in patients with chronic hepatitis B. Arch Iran Med. 2013;16:114–122. doi: 013162/AIM.001323360635
   PubMed Web of Science ®Google Scholar
• Karaivazoglou K, Iconomou G, Triantos C, et al. Fatigue and depressive symptoms associated with chronic viral hepatitis patients. health-related quality of life (HRQOL). Ann Hepatol. 2010;9:419–427.21057161
   PubMed Web of Science ®Google Scholar
• Bao ZJ, Qiu DK, Ma X, et al. Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol. 2007;13:3003–3008. doi:10.3748/wjg.v13.i21.300317589955
   PubMed Web of Science ®Google Scholar
• Patidar KR, Bajaj JS. Tired of hepatitis B? Dig Dis Sci. 2016;61:953–954. doi:10.1007/s10620-016-4067-826874692
   PubMed Web of Science ®Google Scholar
• Meeusen R, Piacentini MF. Exercise, fatigue, neurotransmission and the influence of the neuroendocrine axis. Adv Exp Med Biol. 2003;527:521–525.15206769
   PubMed Web of Science ®Google Scholar
• Piper BF, Cella D. Cancer-related fatigue: definitions and clinical subtypes. J Natl Compr Canc Netw. 2010;8:958–966.20870639
   PubMed Web of Science ®Google Scholar
• Yates P, Aranda S, Hargraves M, et al. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2005;23:6027–6036. doi:10.1200/JCO.2005.01.27116135471
   PubMed Web of Science ®Google Scholar
• Ahmadidarrehsima S, Mohammadpourhodki R, Ebrahimi H, Keramati M, Dianatinasab M. Effect of foot reflexology and slow stroke back massage on the severity of fatigue in patients undergoing hemodialysis: a semi-experimental study. J Complement Integr Med. 2018;15(4).
   Google Scholar
• Wang K, Qi S, Lai H, Zhu X, Fu G. Clinical massage therapy for patients with cancer-related fatigue protocol of a systematic review. Medicine (Baltimore). 2018;97:e13440. doi:10.1097/MD.000000000001344030544425
   PubMed Web of Science ®Google Scholar
• Lim JH, Kim H, Jeon C, Cho S. The effects on mental fatigue and the cognitive function of mechanical massage and binaural beats (brain massage) provided by massage chairs. Complement Ther Clin Pract. 2018;32:32–38. doi:10.1016/j.ctcp.2018.04.00830057053
   PubMed Web of Science ®Google Scholar